Study Information
Status: Completed
Study Details
View study details on clinicaltrials.gov.
Locations
Not Specified
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase 3 Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of Clostridium Difficile Infection (CDI) in Adults
Location: PAMF (Peninsula/South Bay)
Please contact Elizabeth Jameiro jameire@sutterhealth.org about SERES-012